Mesenchymal Stem Cell-derived Exosomes for the Treatment of Bronchiectatic Nontuberculous Mycobacterial Pulmonary Disease

Read full text Summarise with VIRAT
Authors: Gaoxiang Wu, Fei He
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic and challenging infectious condition with rising global prevalence, and its bronchiectatic subtype is particularly difficult to treat with conventional regimens due to frequent adverse effects, thus necessitating novel therapeutic approaches. This report presents a 42-year-old female patient diagnosed with bronchiectatic NTM-PD, characterized by persistent cough, sputum production, and hemoptysis, which was confirmed through radiological findings and microbiological testing. Following intolerance to conventional antimicrobial therapy, the patient was treated exclusively with nebulized inhalation of human umbilical cord mesenchymal stem cell-derived exosomes (HucMSC-Exos). This intervention led to significant alleviation of respiratory symptoms, stabilization of pulmonary function, and marked improvement in immunological parameters. In conclusion, nebulized HucMSC-Exos therapy demonstrated successful outcomes in this case, improving clinical symptoms, pulmonary function, and immune status, which suggests its potential as a viable and innovative therapeutic strategy for managing this complex condition and warrants further clinical investigation.

Fields of Study & Subjects

Mycobacterium research and diagnosis Extracellular vesicles in disease Tuberculosis Research and Epidemiology

Publication details

Journal / source
International Journal of Mycobacteriology
Volume
15
Issue
1
Pages
64–67
Publication date
1 January 2026
Language
EN